Maternal and fetal genetic variation in vitamin D metabolism and umbilical cord blood 25-hydroxyvitamin D
Maternal and fetal genetic variation in vitamin D metabolism and umbilical cord blood 25-hydroxyvitamin D
Context: Single nucleotide polymorphisms (SNPs) in vitamin D metabolism pathway genes are associated with circulating 25-hydroxyvitamin D (25(OH)D) in adults. Less is known about the relationships between mother and offspring SNPs and umbilical cord blood 25(OH)D. Objective: (1) To undertake a meta-analysis of the relationships of maternal and offspring SNPs in the vitamin D metabolism pathway and cord blood 25(OH)D in pregnant women including novel data; and (2) to examine these relationships in women who received antenatal cholecalciferol supplementation in a clinical trial. Methods: Novel data analysis from an observational mother-offspring cohort study (Southampton Women's Survey) and the MAVIDOS double-blind, randomized, placebo-controlled trial of 1000 IU/day cholecalciferol supplementation in pregnancy, and an electronic literature search of published studies in PubMed up to 31 July 2021. Studies reporting associations between rs12785878 (DHCR7), rs10741657 (CYP2R1), rs6013897 (CYP24A1), or rs2282679 (GC) and cord blood 25(OH)D. One published study was included in addition to the novel data analysis. Associations between both maternal and offspring SNPs at rs2282679 (GC) and rs12785878 (DHCR7), and cord blood 25(OH)D were identified. When maternal genotype was adjusted for offspring genotype, and vice versa, there was persisting evidence for associations with maternal rs12785878 (β [95% CI] 1.6 nmol/L [0.3, 2.8] per common allele), and offspring rs2282679 (β 3.1 nmol/L ]2.0, 4.4] per common allele). Maternal and offspring SNPs at rs1074657 and rs613897 were not associated with cord blood 25(OH)D. Result: Associations between both maternal and offspring SNPs at rs2282679 (GC) and rs12785878 (DHCR7), and cord blood 25(OH)D were identified. When maternal genotype was adjusted for offspring genotype, and vice versa, there was persisting evidence for associations with maternal rs12785878 (β [95% CI] 1.6 nmol/L [0.3, 2.8] per common allele), and offspring rs2282679 (β 3.1 nmol/L ]2.0, 4.4] per common allele). Maternal and offspring SNPs at rs1074657 and rs613897 were not associated with cord blood 25(OH)D. Conclusion: Common genetic variation in the vitamin D metabolism pathway is associated with umbilical cord blood 25(OH)D.
25-hydroxyvitamin D, DHCR7, GC, single nucleotide polymorphism, umbilical cord blood, vitamin D
E3403-E3410
Moon, Rebecca
954fb3ed-9934-4649-886d-f65944985a6b
Cooke, Laura, Diana Frances
89a0097e-fbf7-4485-a80b-1f890d824de6
D'angelo, Stefania
13375ecd-1117-4b6e-99c0-32239f52eed6
Curtis, Elizabeth
12aba0c3-1e9e-49ef-a7e9-3247e649cdd6
Titcombe, Philip
a84c9fad-0580-42f9-8bb6-db0fe20435aa
Davies, Justin
9f18fcad-f488-4c72-ac23-c154995443a9
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Cleal, Jane
18cfd2c1-bd86-4a13-b38f-c321af56da66
Lewis, Rohan
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
1 August 2022
Moon, Rebecca
954fb3ed-9934-4649-886d-f65944985a6b
Cooke, Laura, Diana Frances
89a0097e-fbf7-4485-a80b-1f890d824de6
D'angelo, Stefania
13375ecd-1117-4b6e-99c0-32239f52eed6
Curtis, Elizabeth
12aba0c3-1e9e-49ef-a7e9-3247e649cdd6
Titcombe, Philip
a84c9fad-0580-42f9-8bb6-db0fe20435aa
Davies, Justin
9f18fcad-f488-4c72-ac23-c154995443a9
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Cleal, Jane
18cfd2c1-bd86-4a13-b38f-c321af56da66
Lewis, Rohan
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Moon, Rebecca, Cooke, Laura, Diana Frances, D'angelo, Stefania, Curtis, Elizabeth, Titcombe, Philip, Davies, Justin, Godfrey, Keith, Cleal, Jane, Lewis, Rohan, Cooper, Cyrus and Harvey, Nicholas
(2022)
Maternal and fetal genetic variation in vitamin D metabolism and umbilical cord blood 25-hydroxyvitamin D.
Journal of Clinical Endocrinology & Metabolism, 107 (8), .
(doi:10.1210/clinem/dgac263).
Abstract
Context: Single nucleotide polymorphisms (SNPs) in vitamin D metabolism pathway genes are associated with circulating 25-hydroxyvitamin D (25(OH)D) in adults. Less is known about the relationships between mother and offspring SNPs and umbilical cord blood 25(OH)D. Objective: (1) To undertake a meta-analysis of the relationships of maternal and offspring SNPs in the vitamin D metabolism pathway and cord blood 25(OH)D in pregnant women including novel data; and (2) to examine these relationships in women who received antenatal cholecalciferol supplementation in a clinical trial. Methods: Novel data analysis from an observational mother-offspring cohort study (Southampton Women's Survey) and the MAVIDOS double-blind, randomized, placebo-controlled trial of 1000 IU/day cholecalciferol supplementation in pregnancy, and an electronic literature search of published studies in PubMed up to 31 July 2021. Studies reporting associations between rs12785878 (DHCR7), rs10741657 (CYP2R1), rs6013897 (CYP24A1), or rs2282679 (GC) and cord blood 25(OH)D. One published study was included in addition to the novel data analysis. Associations between both maternal and offspring SNPs at rs2282679 (GC) and rs12785878 (DHCR7), and cord blood 25(OH)D were identified. When maternal genotype was adjusted for offspring genotype, and vice versa, there was persisting evidence for associations with maternal rs12785878 (β [95% CI] 1.6 nmol/L [0.3, 2.8] per common allele), and offspring rs2282679 (β 3.1 nmol/L ]2.0, 4.4] per common allele). Maternal and offspring SNPs at rs1074657 and rs613897 were not associated with cord blood 25(OH)D. Result: Associations between both maternal and offspring SNPs at rs2282679 (GC) and rs12785878 (DHCR7), and cord blood 25(OH)D were identified. When maternal genotype was adjusted for offspring genotype, and vice versa, there was persisting evidence for associations with maternal rs12785878 (β [95% CI] 1.6 nmol/L [0.3, 2.8] per common allele), and offspring rs2282679 (β 3.1 nmol/L ]2.0, 4.4] per common allele). Maternal and offspring SNPs at rs1074657 and rs613897 were not associated with cord blood 25(OH)D. Conclusion: Common genetic variation in the vitamin D metabolism pathway is associated with umbilical cord blood 25(OH)D.
Text
JCEM MAVIDOS SNPs 31032022 no endnote clean
- Accepted Manuscript
Text
dgac263
- Accepted Manuscript
More information
Accepted/In Press date: 22 April 2022
e-pub ahead of print date: 26 April 2022
Published date: 1 August 2022
Additional Information:
Funding Information:
This work was supported by grants from the Arthritis Research UK (17702), Medical Research Council (MC_PC_21003; MC_PC_21001), Bupa Foundation, National Institute for Health Research (NIHR) Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, and NIHR Musculoskeletal Biomedical Research Unit, University of Oxford. The work leading to these results was supported by the European Union’s Seventh Framework Programme (FP7/2007-2013), projects EarlyNutrition and ODIN under grant agreements numbers 289346 and 613977. K.M.G. is supported by the National Institute for Health Research (NIHR Senior Investigator (NF-SI-0515-10042) and NIHR Southampton 1000DaysPlus Global Nutrition Research Group (17/63/154)), the European Union (Erasmus + Programme ImpENSA 598488-EPP-1-2018-1-DE-EPPKA2-CBHE-JP) and the British Heart Foundation (RG/15/17/3174, SP/F/21/150013). R.J.M. and E.M.C. are funded by NIHR Academic Clinical Lectureships. L.D.F.C. is supported by the Gerald Kerkut Charitable Trust. We are extremely grateful to Merck GmbH for the kind provision of the Vigantoletten supplement in the MAVIDOS trial. Merck GmbH had no role in the trial execution, data collection, analysis, or manuscript preparation.
Funding Information:
R.J.M., L.D.F.C., S.D., J.C., and R.L. have nothing to disclose. C.C. reports personal fees from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, and Takeda, outside the submitted work. N.C.H. reports personal fees, consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, and Internis Pharma, outside the submitted work. K.M.G. reports reimbursement for speaking at Nestle Nutrition Institute conferences, grants from Abbott Nutrition and Nestec, outside the submitted work; in addition, K.M.G. has a patent Phenotype Prediction pending, a patent Predictive Use of CpG Methylation pending, and a patent Maternal Nutrition Composition pending, not directly related to this work. P.T. is part of academic research programs that have received research funding from Abbott Nutrition, Nestec, and Danone, outside the submitted work. J.H.D. has received travel bursaries from Novo Nordisk, SANDOZ, and Pfizer unrelated to this work. E.M.C. reports lecture fees and travel support from Eli Lilly, Pfizer, and UCB, outside the submitted work.
Publisher Copyright:
© 2022 Endocrine Society. All rights reserved.
Keywords:
25-hydroxyvitamin D, DHCR7, GC, single nucleotide polymorphism, umbilical cord blood, vitamin D
Identifiers
Local EPrints ID: 457055
URI: http://eprints.soton.ac.uk/id/eprint/457055
ISSN: 0021-972X
PURE UUID: 19612e4d-1c46-4434-8d72-a094c57de7dd
Catalogue record
Date deposited: 20 May 2022 16:49
Last modified: 18 Mar 2024 05:08
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
